Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit decoding site, also known as the decoding center (DC), is a fundamental functional region within the small ribosomal subunit responsible for ensuring the fidelity of protein synthesis [2, 6]. It is primarily composed of the 16S ribosomal RNA (rRNA), specifically the aminoacyl-tRNA binding site (A-site) at the top of helix 44, and is stabilized by ribosomal proteins such as uS12 [2, 10]. During translation, the decoding site monitors the base-pairing between the mRNA codon and the tRNA anticodon; a correct match triggers the flipping out of conserved adenine residues (A1492 and A1493), which signals the ribosome to proceed with peptide bond formation [7, 10]. This site is a major target for several classes of antibiotics, most notably aminoglycosides and tetracyclines [1, 13]. Aminoglycosides bind to the decoding site and lock the conserved adenines in the flipped-out conformation, causing the ribosome to accept incorrect tRNAs and leading to the synthesis of nonfunctional or toxic proteins [4, 11]. Because of its essential role in bacterial viability and its structural divergence from eukaryotic counterparts, it remains a critical target for antimicrobial therapy, although its clinical use is often constrained by side effects like ototoxicity and nephrotoxicity [6, 11].
Aminoglycosides bind to the 16S rRNA at the decoding site, inducing a conformational change in nucleotides A1492 and A1493 that mimics a correct codon-anticodon match, thereby promoting the acceptance of near-cognate tRNAs and leading to mRNA misreading and mistranslation [1, 4, 10]. Tetracyclines bind to the A-site to sterically block the entry of aminoacyl-tRNA, effectively halting protein elongation [1, 9, 12].
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit decoding site (30S DC).